with serial FDA approvals, there will be institutional buyers accumulating this stock. Started an initial position and will add on weakness.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
